← Back to PAWORIQ

Dog Seizure Monitoring Wearables in 2026: PetPace, Seizure Apps, and Vet Data Compared

Compare dog seizure monitoring wearables, PetPace, Epi-Moni research, and seizure diary apps—and learn what they can and cannot tell your vet.

Dog Seizure Monitoring Wearables in 2026: PetPace, Seizure Apps, and Vet Data Compared

If your dog has seizures, the key buying question is not simply “Which tracker is best?” It is: Do you need automatic event detection and alerts, or a better way to document seizures for your veterinarian?

Those are different jobs. A health-monitoring collar may collect physiological and activity data, while a seizure app may depend entirely on you entering observations after an event. A research system may show promising detection performance but still lack validation in ordinary homes. None of these tools should be treated as a diagnosis, a guarantee that every seizure will be detected, or a replacement for veterinary care.

This guide compares the main categories available or being evaluated in 2026: PetPace’s health-monitoring collar and epilepsy beta, the research-stage Epi-Moni system, and app-based seizure diaries from the Royal Veterinary College (RVC) and Ringo.

Quick comparison

| Option | What it primarily does | Automatic sensor detection? | Best fit | Important limitation | |---|---|---:|---|---| | PetPace Smart Health Collar | Monitors health, behavior, activity, and selected vital-sign trends | Marketed yes, through its epilepsy beta | Owners seeking continuous monitoring, alerts, and veterinary data sharing | Epilepsy capability is described as beta or early access; independent performance data are limited | | PetPace Epilepsy Monitoring Beta | Uses collar data to flag seizure events and patterns | Marketed yes | Dogs whose owners and veterinarians want physiological and behavioral trends | Qualification and availability may apply; alerts are not a confirmed diagnosis | | Epi-Moni research system | Detects generalized tonic-clonic seizure-like movement using an accelerometer and smartphone | Yes, in the study | Understanding the current research evidence | Small in-hospital evaluation; not established as a generally available home product | | RVC Pet Epilepsy Tracker | Owner-entered seizure, medication, and medical-history records | No verified automatic detection | Creating structured reports for a veterinarian | It cannot observe an unattended seizure automatically | | Ringo | Seizure, medication, trigger, and recovery journaling | No; it describes itself as a journaling tool | Free, offline-capable recordkeeping and report export | Not a medical device and not a veterinary diagnosis tool |

1. PetPace: the most direct wearable option, but not a proven all-seizure detector

PetPace describes its Smart Health Collar as a continuous health-monitoring device. Its listed data include pulse, heart-rate variability, respiration, temperature, posture, activity, sleep, behavior, and GPS. The company also markets AI-powered insights, near-real-time alerts, veterinary data access, and telemedicine features.

For a dog with suspected epilepsy, the attraction is clear: a collar may collect information during periods when nobody is watching. Instead of relying only on a family member noticing an event, the system is designed to look for changes across several signals.

PetPace’s epilepsy monitoring page says the system uses heart-rate variability, respiration, temperature, posture, and activity data to flag seizure events and patterns. It also says the resulting logs and vital-sign trends can help owners and veterinarians review timing and treatment-related information.

However, the epilepsy capability is currently presented as an “Epilepsy Beta” or early-access module. Enrollment may depend on qualification and availability. That distinction matters: PetPace’s product claims should be separated from independently validated clinical performance data. The reviewed information does not establish that the collar reliably detects every seizure type, predicts seizures, or replaces a veterinary diagnosis.

The product page also states that a subscription is required for device features and telemedicine. Before purchasing, confirm current eligibility, supported features, subscription terms, data sharing, and availability directly with PetPace.

Who should consider PetPace?

PetPace is the closer match if your priority is continuous monitoring with the possibility of alerts and veterinary data sharing, rather than a simple diary. Discuss it with your veterinarian first, especially if your dog has focal seizures, subtle episodes, medication changes, or another condition that could affect heart rate, breathing, posture, or activity.

Treat an alert as a prompt to investigate—not as proof that a seizure occurred. Likewise, a quiet period without an alert does not prove that no seizure happened.

2. Epi-Moni: encouraging research evidence, not a ready-made consumer buying choice

The strongest published performance figures in the supplied research concern Epi-Moni, an app-based system evaluated in dogs. The setup used a three-axis accelerometer attached in a jacket over the interscapular region and communicated with a smartphone through Bluetooth Low Energy.

In the 2025 in-hospital evaluation, the system detected 26 of 35 generalized tonic-clonic seizures. That represented 74.3% sensitivity, with a median detection latency of 11 seconds. The study reported a false-positive rate of 0.018 events per day and a positive predictive value of 92.6%.

Those numbers are useful because they provide measured performance rather than only promotional language. But they need context. The study involved 12 dogs in a hospital or temporarily housed setting, and spontaneous generalized tonic-clonic seizures were observed in only four dogs. The system was not designed to detect focal seizures, and the authors recommended further testing in home environments.

Epi-Moni therefore belongs in the research evidence column, not automatically in the consumer shopping column. The publication does not establish that it is a generally available home product, that it works with a conventional collar, or that it detects every canine seizure phenotype.

For buyers, the lesson is broader: ask what was measured, where the testing occurred, how many dogs and events were included, and which seizure types were studied. A result for generalized tonic-clonic seizures should not be generalized to focal, subtle, or non-convulsive events.

3. Seizure diary apps: lower-tech, but often highly useful for veterinary decisions

A diary app does not automatically detect an unattended seizure. Its value is different: it helps you record what happened, when it happened, how long it lasted, what medication was given, and how your dog recovered.

The RVC Pet Epilepsy Tracker is designed for owner-entered seizure and medication records. It also supports reminders, medical-history notes, professional contact information, educational content, and exportable reports for veterinarians. Based on the verified information, it is a tracking and communication tool rather than an automatic seizure-detection collar.

Ringo describes itself as a free journaling and community app for canine epilepsy. Its features include seizure and medication logging, possible-trigger analysis, offline entry, environmental data, and exportable reports. Ringo explicitly states that it is not a medical device and does not provide veterinary diagnosis or treatment advice.

For many households, a structured diary may be more immediately useful than an unvalidated alert. Your veterinarian may need seizure frequency, duration, clustering, medication timing, missed doses, recovery behavior, and possible triggers when evaluating treatment. A consistent record can make that information easier to review.

The main weakness is observation bias: if nobody sees the event, an owner-entered app cannot record it automatically. A diary also depends on accurate and timely entry. If possible, record video safely from a distance, note the start and end time, and follow your veterinarian’s instructions about emergency medication.

A practical framework for choosing a system

Choose your primary job

Start with the outcome you need:

Automatic monitoring or remote alerts: investigate a health-monitoring wearable such as PetPace, while recognizing its epilepsy module is beta and not independently established as a universal detector.
Better seizure and medication records: choose a diary such as the RVC tracker or Ringo.
Research-grade understanding: read studies such as the Epi-Moni evaluation, but do not assume a research setup is available or validated for home use.
Both: use a wearable if appropriate and maintain a manual diary. Sensor data and owner observations answer different questions.

Check what the system actually measures

Movement-only detection is not the same as physiological monitoring. Epi-Moni’s published evaluation used an accelerometer and targeted generalized tonic-clonic seizures. PetPace markets a broader combination of activity, posture, and physiological signals. Apps such as RVC’s tracker and Ringo primarily depend on owner-entered records.

Ask whether the product can capture seizure duration, recovery, medication timing, video, notes, and possible triggers—not just whether it sends an alert.

Examine evidence quality

Separate four types of claims:

Peer-reviewed performance data, including the population, setting, seizure types, sensitivity, false positives, and limitations.
Vendor-reported capabilities, such as PetPace’s beta epilepsy features.
Owner-entered records, which can be valuable but are not automatic detection.
Marketing language, which should not be treated as clinical validation.

Also check comfort, fit, battery and charging routines, connectivity, phone dependence, data export, privacy, and whether the dog will reliably wear the device. Confirm whether a subscription is required for alerts, storage, sharing, telemedicine, or advanced analytics.

Safety: monitoring technology does not replace veterinary care

A wearable or app cannot determine the cause of a seizure or decide whether antiseizure medication should be started, stopped, or changed. The Merck Veterinary Manual explains that medication decisions depend on documented seizure frequency, clusters, status epilepticus, clinical response, adverse effects, and veterinary monitoring.

Seek immediate veterinary treatment if a seizure lasts more than five minutes or if several seizures occur in rapid succession, according to VCA Animal Hospitals. Do not put your hands in your dog’s mouth or try to interrupt the seizure. Follow your veterinarian’s emergency plan, including any instructions for rescue medication.

Bottom line

For a dog seizure monitoring wearable, PetPace is the clearest current commercial option in the reviewed material, but its epilepsy feature is presented as a beta or early-access capability rather than a fully validated consumer medical diagnostic. Epi-Moni offers useful research evidence for detecting some generalized tonic-clonic seizures, but its small in-hospital study should not be mistaken for broad home validation.

If your immediate goal is better veterinary communication, an app-based diary may be the most dependable starting point. If your goal is unattended monitoring, discuss a wearable with your veterinarian and use any alert as supporting information—not a diagnosis. The best system is the one that fits your dog, produces records your veterinary team can use, and complements rather than replaces clinical care.

Sources

Affiliate disclosure: This page may contain affiliate links. If you buy through one of these links, the site may earn a commission at no additional cost to you.